biotech and therapies

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

Synimmune GmbH

Biotech and Therapies

Synimmune GmbH is a biotechnology company dedicated to the development of innovative and effective mono-and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with a focus on orphan hematopoietic malignancies.

Learn more

alytas therapeutics GmbH

Biotech and Therapies

Alytas Therapeutics GmbH was incorporated in 2018 as a spin-off of the University of Jena and is based inJena, Germany. Its founders are experts in lipid-associated metabolic disorders and associated co-morbidities (like obesity).

Learn more

clyxop devices GmbH

Biotech and Therapies

The clyxop devices UG develops tubes, based on biocellulose, that can be used as a bridging agent in cases of damage to hollow organs and stimulate tissue regeneration.

Learn more

inflamed pharma GmbH

Biotech and Therapies

inflamed pharma GmbH produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients applied in innovative therapies for human and veterinary medicine.

Learn more

Lysatpharma GmbH

Biotech and Therapies

Lysatpharma GmbH is an innovation-based startup company in the field of biotechnological research and development.

Learn more

x-nuclear diagnostics GmbH

Biotech and Therapies

x-nuclear diagnostic GmbH is a spin-off of University Hospital (Universitätsklinikum) Jena founded in 2019 and based in Erfurt, Germany.

Learn more

x-kidney diagnostics GmbH

Biotech and Therapies

x-kidney diagnostics GmbH was incorporated in 2019 and is based in Erfurt, Germany. The company is dedicated to the development of new methods for the early identification of kidney diseases.

Learn more

Ix Therapeutics GmbH

Biotech and Therapies

The Ix Therapeuthics GmbH is a joint venture company founded by the Company and Indivumed GmbH in March 2021

Learn more

Sign up for our media releases

We regularly report on the business development of Xlife Sciences AG and our project companies.